CME Group, Chubb, Berkshire Hathaway And More On CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
On CNBC's 'Final Trades', experts discussed CME Group, Chubb, Berkshire Hathaway, and iShares U.S. Medical Devices ETF. CME Group reported record July ADV, Chubb posted strong earnings, Berkshire Hathaway received a Hold rating, and iShares U.S. Medical Devices ETF was highlighted as a final trade.
August 30, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Berkshire Hathaway continues to move higher, with a recent Hold rating and a price target of $465 from TD Cowen.
The Hold rating and price target suggest a neutral short-term outlook, indicating limited immediate upside potential.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
iShares U.S. Medical Devices ETF was highlighted as a final trade, rising 0.5% during Thursday's session.
The mention as a final trade suggests interest but does not indicate a significant short-term impact on the ETF's price.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Chubb posted better-than-expected Q2 earnings with EPS of $5.38 and sales of $11.780 billion, beating estimates.
Chubb's strong earnings performance is likely to positively impact its stock price in the short term as it exceeded market expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
CME Group reported a record July ADV of 24.8 million contracts, up 24% YoY. The stock yields a 4.5% dividend and trades at a forward PE of 21.
CME's record ADV and attractive dividend yield suggest positive investor sentiment, likely boosting short-term stock performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80